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Vinuesa E, Sola A, Jung M, Alfaro V, Hotter G. Lipocalin-2-
induced renal regeneration depends on cytokines. Am J Physiol Renal
Physiol 295: F1554–F1562, 2008. First published September 24,
2008; doi:10.1152/ajprenal.90250.2008.—This study investigated
whether the renal regeneration occurring in the recovery phase of
kidney ischemia-reperfusion (I/R) is mediated by endogenously gen-
erated lipocalin-2 (Lcn2). A second objective was to examine whether
Lcn2-mediated cell effects could be regulated by the inflammatory
cytokines in the environment through their action on Lcn2 receptors
(Lcn2R and megalin). Male Swiss mice were subjected to 30 min of
renal ischemia with a reperfusion period of 24 h (early reperfusion,
expected time for maximum inflammation) and 96 h (late reperfusion,
expected time for maximum regeneration). Different experimental
groups underwent I/R, I/R with iv anti-mouse Lcn2 monoclonal
antibody injected during the early/inflammatory or late/recovery
phase, and I/R with proinflammatory cytokine cocktail administration
(recombinant mouse IL-1, TNF-, and IFN-). Compared with
control nonischemic mice, the expression of three proliferation mark-
ers (stathmin, PCNA, and Ki-67, analyzed by quantitative RT-PCR)
increased significantly in the I/R-treated animals. Blockade of Lcn2
by addition of anti-Lcn2 antibody significantly decreased the expres-
sion of these three proliferation markers when administered in the
late/reparative phase, but had the opposite effect when administered in
the early/inflammatory phase. Proinflammatory cytokine cocktail ad-
ministration reduced the proliferative effects of Lcn2, and repressed
Lcn2R and megalin expression. In conclusion, endogenously gener-
ated Lcn2 induces renal cell regeneration depending on the inflam-
matory cytokines in kidney I/R.
Lcn2; mice; kidney; tubular cells; ischemia-reperfusion; cell regener-
ation
ACUTE OR CHRONIC LOW-GRADE ischemia is the main cause of
renal failure (10). The initial phase of ischemia-reperfusion
(I/R) (i.e., the first 24 h after reperfusion) involves the onset
and progression of tissue injury and is characterized by loss of
cell polarity, increased cell swelling, loss of adherence to the
extracellular matrix, and cell death (32). The injury phase is
followed by the recovery phase, which at the cellular level is
manifested by an increase in dedifferentiated and mitotic cells
in the damaged areas (16). The presence of these dedifferen-
tiated, mitotic cells indicates an ongoing regenerative process
after kidney I/R injury. Nevertheless, cells involved in the
regenerative process of renal tissue include a smaller number
of cells derived from the bone marrow (i.e., stem cells) (14).
The identification of interventions that might enhance the
recovery phase is of considerable interest, because improved
knowledge of the mediators of this cell regeneration may be
critical for developing new innovative and effective therapies.
Previous studies have shown that neutrophil gelatinase-associ-
ated lipocalin (Lcn2/NGAL), a novel early urinary biomarker
for ischemic renal injury, is upregulated in tubular epithelial
cells undergoing proliferation in the postischemic kidney (21).
Renoprotective effects have been found for Lcn2 administered
in vivo to I/R-injured mice (22). Lcn2 plays a regulatory role
in epithelial morphogenesis in the mouse by promoting the
organization of cells into tubular structures (15). As Lcn2 is
massively upregulated after renal tubular injury and may par-
ticipate in limiting kidney damage (30), we hypothesized that
the injury vs. reparative phases of I/R might both be mediated
by different Lcn2 effects.
In renal tubular cells, Lcn2 may be induced by the local
release of cytokines such as HGF from renal epithelial cells or
infiltrated inflammatory cells (6, 11, 15). This is also postulated
in other pathologies, in which Lcn2 induction is the result of
interactions between inflammatory cells or cytokines and the
epithelial lining (1, 3, 18, 23, 35). Although the effects of
cytokines on Lcn2 induction have been previously assessed, no
studies so far have investigated the effect of cytokines on the
modification of Lcn2 function.
Megalin, a multifunctional scavenger receptor highly ex-
pressed in kidney epithelial cells, binds Lcn2 with high affinity
(2) and functions as a receptor for Lcn2 (17). Devireddy et al.
(9) isolated a specific cell-surface receptor of Lcn2 [a highly
conserved protein named brain-type organic cation transporter
(BOCT)], Lcn2R, from murine cells, and later Richardson et al.
(27) presented evidence that some oncoproteins that increase
expression of apo-NGAL (the human homolog of Lcn2) could
repress the expression of its receptor (NGALR). To date, no
studies have attempted to identify the effect of cytokines on
Lcn2R expression.
Bearing in mind that renal regeneration is dependent on
inflammatory cytokines (8, 13, 33) and that Lcn2, being an
inducer of renal regeneration, could be modulated by cyto-
kines, we decided to investigate the involvement of both
factors in the regenerative process associated with renal I/R.
The present study was designed to investigate whether the
injury vs. reparative phases of I/R might both be mediated by
different Lcn2 effects and whether Lcn2-mediated cell effects
might be regulated by the cytokine environment through its
action on Lcn2 receptors.
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MATERIALS AND METHODS
Mouse Model of Renal I/R Injury
All animal procedures were approved by the Institutional Animal
Care and Use Committee (IACUC) and followed the European Union
guidelines for the handling and care of laboratory animals. Male Swiss
mice (Charles River), weighing 25–30 g, were housed with 12:12-h
light-dark cycle and were allowed free access to food and water. The
animals were anesthetized with isoflurane and body temperature was
maintained at 37°C. Renal pedicles were occluded with a nontrau-
matic vascular clamp for 30 min, while the kidney was kept warm and
moist. Thereafter, clamps were removed, return of kidney blood was
observed, and the incision was sutured. The reperfusion period was
selected based on a previous study (33) in which the maximum
plateau for regeneration was observed at 96 h. After 96 h of reperfu-
sion, the animals were reanesthetized, the abdominal cavity was
opened, and blood was obtained via puncture of the inferior vena cava
to measure blood urea nitrogen (BUN). Mice were killed, and the
kidneys were harvested. One-half of each kidney was snap-frozen in
liquid nitrogen and stored at80°C until further processing. A sample
was fixed in formalin, paraffin-embedded, and sectioned (4 m).
Experimental Groups
The following experimental groups were studied (n  5 each) (see
Table 1).
Control (C). In the control group, animals were subjected to the
identical maneuvers as the I/R group, except that the renal pedicles
were not clamped.
Ischemia/early reperfusion (I/early reperfusion). Animals under-
went 30 min of bilateral ischemia and were killed after 24 h of
reperfusion.
Ischemia/late reperfusion (I/late reperfusion). Animals underwent
30 min of bilateral ischemia and were killed after 96 h of reperfusion.
Ischemia/early reperfusionanti-mLcn2 administration (I/early
reperfusionanti-mLcn2). Animals underwent the same procedure as
the I/R group but were treated with monoclonal anti-mouse Lcn2
antibody (75-g iv bolus) in the inflammatory phase (24 h).
Ischemia/late reperfusionanti-mLcn2 administration (I/late
reperfusionanti-mLcn2). Animals underwent the same procedure as
the I/R group but were treated with monoclonal anti-mouse Lcn2
antibody (75-g iv bolus) in the regenerative phase (72 h). Admin-
istration of anti-Lcn2 antibody has previously been found effective in
reversing Lcn2-associated effects (26).
Rat IgG administration (I/late reperfusionrat IgG). As a control
group, animals underwent the same procedure as the I/R group but
were treated with (75-g iv bolus) in the regenerative phase (72 h).
Proinflammatory cytokine cocktail administration (I/late reperfusion
cytokines). Animals underwent the same procedure as the I/R group but
also received an infusion of a proinflammatory cytokine cocktail (200
l ip) 1 day before death.
Lcn2 Antibody and Rat IgG Administration
Mice were injected intravenously via the tail vein with 150 l of
PBS containing 75 g of monoclonal anti-mouse Lcn2 antibody
(R&D Systems) or rat IgG (R&D Systems), respectively.
Cytokine Administration
To modulate the inflammatory response, mice were treated intra-
peritoneally with a proinflammatory cytokine cocktail containing 200
l of PBS with recombinant mouse IL-1 (100 ng), TNF- (2 g),
and IFN- (750 ng). All cytokines were provided by Invitrogen. These
or similar doses of mouse/rat cytokines have previously been found to
exert biological effects in murine inflammation models (5, 20, 29, 34).
Table 1. Experimental groups in the study
Reperfusion Period, h
24 (Early) 72 96 (Late) Group
Anti-Lcn2 administration * *  I/early reperfusionanti-mLcn2
*  I/late reperfusionanti-mLcn2
Rat IgG administration *  I/late reperfusionrat IgG
Cytokine cocktail administration *  I/late reperfusion  cytokines
Lcn2, lipocalin-2. *Administration point. Euthanasia point.
Table 2. Sequences, annealing temperature, and expected fragment size of primers utilized in real-time qRT-PCR
Gene (Accession No.) Source Primer Sequences Annealing Temperature, °C Amplicon Length, bp
GAPDH (NM_008084) Invitrogen Forward 5-TGA-AGC-AGG-CAT-CTG-AGG-G-3
Reverse 5-CGA-AGG-TGG-AAG-AGT-GGG-AG-3
49 102
Stathmin (NM_019641) Invitrogen Forward 5-CTT-GCG-AGA-GAA-GGA-CAA-GC-3
Reverse 5-CGG-TCC-TAC-ATC-GGC-TTC-TA-3
49 200
PCNA (NM_011045) Invitrogen Forward 5-AAT-GGG-GTG-AAG-TTT-TCT-GC-3
Reverse 5-CAG-TGG-AGT-GGC-TTT-TGT-GA-3
49 173
Ki-67 (NM_001081117) Invitrogen Forward 5-CAG-TAC-TCG-GAA-TGC-AGC-AA-3
Reverse 5-CAG-TCT-TCA-GGG-GCT-CTG-TC-3
49 170
Lipocalin-2 (NM_008491) Invitrogen Forward 5-CAA-GTG-GCC-GAC-ACT-GAC-TA-3
Reverse 5-GGT-GGG-AAC-AGA-GAA-AAC-GA-3
49 192
TNF- (NM_013693) Invitrogen Forward 5-AAC-TCC-CAG-AAA-AGC-AAG-CA-3
Reverse 5-CGA-GCA-GGA-ATG-AGA-AGA-GG-3
50 212
Megalin (NM_001081088) Qiagen QuantiTect Primer Assay for SybGreen detection 49 84
IL-10 (NM_010548) Qiagen QuantiTect Primer Assay for SybGreen detection 50 103
MCP-1 (NM_011333) Qiagen QuantiTect Primer Assay for SybGreen detection 55 118
qRT-PCR, quantitative RT-PCR; PCNA, proliferating-cell nuclear antigen.
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Plasma Urea and Creatinine
BUN was determined in plasma using a Sigma diagnostic kit, and
the results are expressed as milligrams per deciliter. Creatinine con-
centrations was determined by a standardized colorimetric assay using
alkaline picrate with a Advia 2400 automated analyzer (Siemens
Medical Solutions Diagnostics) (4, 31) at the Clinical Hospital (Bar-
celona, Spain).
Proliferation Assays
Kidneys were fixed in 4% paraformaldehyde, embedded in paraf-
fin, and cut into sections of 4 m. Immunofluorescent staining of
stathmin and proliferating-cell nuclear antigen (PCNA) were pre-
pared, as previously described (33, 36). Briefly, paraformaldehyde-
fixed, paraffin-embedded sections were washed in PBS and blocked.
Tissue sections were incubated with rabbit anti-stathmin polyclonal
antibody (Calbiochem), which labels dedifferentiated, mitotically ac-
tive epithelial cells, and with mouse anti-PCNA monoclonal antibody
(Santa Cruz Biotechnology), which labels cells in the G1, S, and G2
phases of the cell cycle, followed by incubation with secondary
antibodies (rabbit anti-goat IgG) conjugated with Alexa Fluor 488
for anti-stathmin antibody and goat anti-mouse IgG conjugated with
Alexa Fluor 568 for anti-PCNA antibody (Molecular Probes) for 2 h
at room temperature. Sections were mounted with mowiol (Calbio-
chem) and viewed using a Leica TCS NT laser microscope (Leica
Microsystems). Slides were examined in a blinded manner, and
proliferation was quantified by counting the number of stathmin- and
PCNA-positive cells/100 cells counted in an average of five high-
power fields (	40) in each section. Stathmin is a ubiquitously ex-
pressed cytosolic phosphoprotein (25, 28) that has been identified as
a marker of cell proliferation in the recovery phase of acute ischemic
renal failure (36). Increased expression of stathmin is associated with
the reentry of cells into the cell cycle and the onset of cell proliferation
(7), whereas PCNA labels proliferating nuclei.
Quantitative Real-Time RT-PCR
Total tissue and cell RNAs were extracted from homogenized tissue
with TRIzol Reagent (Invitrogen) according to the manufacturer’s in-
structions, and RNA concentrations were calculated from A260 deter-
minations. One microgram of RNA was reverse transcribed by
using an iScript cDNA Synthesis Kit (Bio-Rad) in a final volume
of 40 l.
Stathmin, PCNA, Ki-67, Lcn2, Lcn2R, megalin, TNF-, MCP-1,
and IL-10 mRNA expression normalized to the housekeeping gene
GADPH were measured by quantitative (q) real-time RT-PCR, using
the appropriate primers (Table 2), performed in a Bio-Rad iCycler iQ
Real-Time PCR Detection System. Amplifications were carried out in
a 20-l reaction volume, using IQ SYBR Green Supermix (Bio-Rad)
according to the manufacturer’s instructions.
In Vitro Test to Study Antibody’s Effect as Blocker of Lcn2 Activity
Mouse RAW 264.7 macrophages (European Collection of Cell
Culture) were cultured in DMEM 1:1 F-12 nutrient supplement with
high glucose, 15 mM HEPES, and stable L-glutamine, supplemented
with 100 U/ml penicillin, 100 g/ml streptomycin, and 10% (vol/vol)
fetal bovine serum (Invitrogen). Cells were kept in a humidified
atmosphere of 5% CO2 in air at 37°C. RAW 264.7 macrophages were
Fig. 1. Representative immunofluorescence
pictures of stathmin (green) and proliferating-
cell nuclear antigen (PCNA; red) staining of
kidney samples. A: control. B: ischemia (I)/late
reperfusion (30 min of ischemia followed by 96 h
of reperfusion). C: I/early reperfusionanti-
mLcn2 [ischemia-reperfusion (I/R) with Lcn2
antibody administration in early reperfusion,
24 h]. D: I/late reperfusionanti-mLcn2 (I/R
with Lcn2 antibody administration in late
reperfusion, 72 h). Images are viewed under
	400 magnification.
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transferred at 70–80% confluence by cell scraping. For the experi-
ments, macrophages were transferred to a six-well plate at a density of
1 	 106 cells/well. Cells were incubated with LPS (15 g/ml, Sigma)
for 24 h to stimulate Lcn2 production (24, 37) before antibody
treatment. Cells were washed with PBS and fresh culture medium
containing either 75 g of a monoclonal antibody against mouse Lcn2
or rat IgG to LPS-stimulated macrophages and incubated for 24 h.
Lcn2 ELISA
Supernatants from the in vitro text cultures were collected and
clarified by centrifugation. Fifty microliters of each sample were
applied to an ELISA as previously described (19). Briefly, 96-well-
plates were previously covered with catch anti-mouse lipocalin-2/
NGAL monoclonal antibody (R&D Systems) and blocked for 1 h.
After sample incubation, biotinylated anti-mouse lipocalin-2/NGAL
antibody (R&D Systems) was added. Afterward, horseradish peroxi-
dase-conjugated avidin (Invitrogen) was incubated for 1 h. Finally,
color reagent (OPD tablets, Dako) was added, and absorbance was
read at 492 nm in a plate reader. All steps were performed at room
temperature.
Statistical Analyses
Data were recorded as means 
 SE. The means of different groups
were compared using one-way ANOVA. The Student-Newman-Keuls
test was performed to evaluate significant differences between groups,
which were assumed to exist when P  0.05.
RESULTS
Lcn2 Influences Tubule Cell Proliferation after
Ischemic Injury
Representative kidney sections stained with antibodies to
stathmin and PCNA are shown in Fig. 1. Nonischemic
control kidneys had a minimal presence of proliferating
cells (2.8 
 0.60 for stathmin and 1.5 
 0.45 for PCNA)
(Fig. 1A); eight fields were counted per sample and aver-
aged. Kidneys subjected to I/R showed a high number of
cells expressing stathmin and PCNA (57 
 1.67 for stath-
min and 26.50 
 1.09 for PCNA) when samples were
obtained during late reperfusion (Fig. 1B); this number was
less when samples were obtained during early reperfusion
(14.3 
 0.82 for stathmin and 9.1 
 1.21 for PCNA).
Animals that were treated with anti-Lcn2 antibody during
early reperfusion (24 h) had a significant increase in the
number of stathmin- and PCNA-positive proximal tubule
epithelial cells (66.2 
 2.05 for stathmin and 36.8 
 1.95
for PCNA) (Fig. 1C). In contrast, animals that were treated
with anti-Lcn2 antibody during late reperfusion (72 h,
regenerative phase) showed a marked decrease in prolifer-
ating proximal tubule cells with respect to the I/R group
(12 
 0.81 for stathmin and 7 
 0.63 for PCNA) (Fig. 1D).
Kidney injury, evaluated as BUN and plasma creatinine,
presented higher injury development during early reperfusion
than during late reperfusion periods. The different treatments
did not modify the increased injury markers (Fig. 2).
Three markers of proliferation (stathmin, PCNA, and Ki-67)
were analyzed by quantitative RT-PCR to determine the in-
volvement of Lcn2 in the recovery of renal tissue after I/R
injury (Fig. 3). The increase in the three proliferation markers
after I/late reperfusion was dramatically reversed after block-
age of Lcn2 at late reperfusion stages. By contrast, anti-Lcn2
antibody administration during early reperfusion significantly
increased the expression of the three proliferation markers.
Administration of rat IgG during late reperfusion did not
modify the increases observed in the three proliferation mark-
ers in the late reperfusion periods. These results provide
evidence of a dual role for Lcn2 as an inducer or inhibitor of
renal cell proliferation.
Effect of Proinflammatory Cytokines on Regeneration
Three markers of proliferation (stathmin, PCNA, and Ki-67)
were analyzed by quantitative RT-PCR to determine the in-
volvement of cytokines in the recovery phase of renal tissue
Fig. 2. Blood urea nitrogen (BUN; A) and plasma creatinine (B) at different
time points of anti-mouse lipocalin-2 (Lcn2) antibody administration. C,
control; I/early reperfusion, 30 min of ischemia followed by 24 h of reperfu-
sion; I/late reperfusion, 30 min of ischemia followed by 96 h of reperfusion;
I/early reperfusionanti-mLcn2, I/R with Lcn2 antibody administration at 24 h
postreperfusion; I/late reperfusionanti-mLcn2, I/R with Lcn2 antibody ad-
ministration at 72 h; I/late reperfusioncytokines, I/R with proinflammatory
cytokine cocktail administration at 72 h; I/late reperfusionrat IgG, I/R with
rat IgG administration at 72 h. Values are means 
 SE (n  5/group). *P 
0.05 vs. control. P  0.05 vs. I/late reperfusion.
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after I/R injury (Fig. 4). The significant increase in the expres-
sion of the three proliferation markers observed in the I/R
group was reversed when the proinflammatory cytokine cock-
tail was administered.
Cytokine Expression
We analyzed cytokine expression by quantitative RT-PCR
(Fig. 5). MCP-1 expression was increased in the I/R group
compared with controls, although, as expected, the highest
expression was observed when the proinflammatory cytokine
cocktail was administered (Fig. 5A) and in the inflammatory
phase (I/early reperfusion). However, the anti-inflammatory
cytokine IL-10 showed different results. I/R showed increased
IL-10 expression compared with controls, but addition of the
proinflammatory cytokine cocktail did not significantly change
IL-10 expression (Fig. 5B).
Lcn2, Lcn2R and Megalin Expression
Lcn2 and Lcn2-receptor mRNA expression was analyzed by
RT-PCR in renal tissue (Fig. 6). Lcn2 expression was increased
in kidneys in the I/R groups with respect to controls. But
significantly higher levels were observed during early reperfu-
sion periods (24 h) with respect to the late reperfusion and
regenerative phase (96 h). Cytokine administration induced
significant increases in Lcn2 levels (Fig. 6A).
By contrast, Lcn2R and megalin expression profiles showed
the opposite behavior to that observed for Lcn2 expression.
Lcn2R and megalin mRNA decreased in the early/inflamma-
tory phase of ischemia (24 h), increased during the late/
reparative phase (96 h), and decreased with cytokine adminis-
tration (Fig. 6, B and C).
In Vitro Test to Study Antibody’s Effect as Blocker
of Lcn2 Activity
As shown in Fig. 7, under normal cell culture conditions,
murine macrophages (RAW 264.7) responded directly to the
addition of LPS by an increase in the expression of Lcn2
mRNA, TNF- mRNA, and Lcn2. Addition of the anti-mLcn2
antibody decreased Lcn2 mRNA expression and Lcn2 protein,
and increased TNF- mRNA, while administration of rat IgG
had no effect, indicating the ability of the anti-mLcn2 antibody
to block various effects classically attributed to Lcn2.
DISCUSSION
In this study, we found that renal regeneration after I/R is
mediated by endogenously generated Lcn2. The regenerative
function of Lcn2 is influenced by the kidney inflammatory
status and the expression of Lcn2 receptors.
Lcn2 is an acute-phase protein involved in multiple apop-
totic events and in proliferation. In the kidney, it is known that
Lcn2 is produced at sites of injury and that may modulate renal
repair and, therefore, kidney integrity (15, 22). In our study, we
found that Lcn2 expression increased significantly in the early/
Fig. 3. Patterns of normalized stathmin (A), PCNA (B), and Ki-67 (C)
mRNA expression assessed by quantitative (q) RT-PCR at different time
points of anti-mouse Lcn2 antibody administration. C, control; I/early
reperfusion, 30 min of ischemia followed by 24 h of reperfusion; I/late re-
perfusion, 30 min of ischemia followed by 96 h of reperfusion; I/early
reperfusionanti-mLcn2, I/R with Lcn2 antibody administration at 24 h
postreperfusion; I/late reperfusionanti-mLcn2, I/R with Lcn2 antibody
administration at 72 h; I/late reperfusioncytokines, I/R with proinflam-
matory cytokine cocktail administration at 72 h; I/late reperfusionrat IgG,
I/R with rat IgG administration at 72 h. Values are means 
 SE (n 
5/group). *P  0.05 vs. control. P  0.05 vs. I/late reperfusion.
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inflammatory and also in the late/reparative phases of post-
ischemic reperfusion. However, Lcn2 blockade with a specific
anti-Lcn2 antibody generates different effects according to the
time of administration; results showed that Lcn2 blockade was
able to reduce the three different markers of regeneration
(stathmin, PCNA, and Ki-67) when administered in the regen-
erative phase, but had the opposite effect when applied in the
inflammatory phase, in which antibody administration pro-
motes regeneration. This finding indicates a dual role of the
endogenously generated Lcn2, which may be either pro- or
antireparative depending on the phase of reperfusion.
Fig. 4. Effect of cytokines on patterns of normalized stathmin (A), PCNA
(B), and Ki-67 (C) mRNA expression assessed by real-time RT-PCR. C,
control; I/early reperfusion, animals subjected to 30 min of bilateral
ischemia and killed after 24 h of reperfusion; I/late reperfusion, animals
subjected to 30 min of bilateral ischemia and killed after 96 h of reperfusion;
I/late reperfusioncytokines, I/R with cytokine administration (recombinant
mouse 100 ng IL-1, 2 g TNF-, and 750 ng INF- ). mRNA expression
normalized to GAPDH is shown as means 
 SE (n  5 each group). *P 
0.05 vs. control. P  0.05 vs. I/late reperfusion.
Fig. 5. Cytokine profiles. qRT-PCR from representative renal injury cytokines
is shown. A: MCP-1 expression. B: IL-10 expression. C, control; I/early
reperfusion, animals subjected to 30 min of bilateral ischemia and killed after
24 h of reperfusion; I/late reperfusion, animals subjected to 30 min of bilateral
ischemia and killed after 96 h of reperfusion; I/late reperfusioncytokines, I/R
with cytokine administration. Values are means 
 SE (n  5/group). *P 
0.05 vs. control. P  0.05 vs. I/late reperfusion.
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Previous studies have shown that cell regeneration vs. injury
during the renal I/R process are directly related to inflamma-
tory activity. Maximum cell regeneration occurred during
phases in which an anti-inflammatory environment (repre-
Fig. 6. Patterns of normalized stathmin Lcn2 (A), Lcn2 receptor (Lcn2R; B),
and megalin (C) mRNA expression in renal tissue assessed by quantitative
real-time RT-PCR at different time points of anti-mouse Lcn2 antibody
administration. C, control; I/early reperfusion, animals subjected to 30 min of
bilateral ischemia and killed after 24 h of reperfusion; I/late reperfusion,
animals subjected to 30 min of bilateral ischemia and killed after 96 h of
reperfusion; I/late reperfusioncytokines, I/R with cytokine cocktail admin-
istration (100 ng IL-1, 2 g TNF-, and 750 ng IFN- ). mRNA expression
normalized to GAPDH is shown as means 
 SE (n  5/group). *P  0.05 vs.
control. P  0.05 vs. I/late reperfusion.
Fig. 7. Biological effect of anti-mLcn2 antibody. Normalized Lcn2 (A) and
TNF- (B) mRNA expression assessed by qRT-PCR, and Lcn2 (C) assessed
by ELISA in LPS-stimulated RAW 264.7 cell culture, under the action of
anti-mouse Lcn2 antibody and rat IgG. *P  0.05 vs. resting RAW 264.7.
P  0.05 vs. LPS-stimulated RAW 264.7.
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sented by maximum levels of IL-10) (33) prevailed. Our results
indicate that during the early/inflammatory phase of reperfu-
sion, Lcn2 does not induce proliferation, but that during the
anti-inflammatory and reparative phases it acts as an inducer of
proliferation, suggesting that an anti-inflammatory environ-
ment may be a requisite for Lcn2 to induce renal cell regen-
eration. In fact, we have detected that during the late/reparative
phase, increases in the proliferative markers are concomitant
with significant increases in the anti-inflammatory cytokine
IL-10.
The effect of inflammatory cytokines on Lcn2 expression
has been studied previously. Lcn2 is upregulated in response to
inflammation in neoplastic tissues and in inflammatory bowel
diseases, and its expression also increases in epithelial cells
after stimulation with proinflammatory cytokines (12, 23).
However, the effect of inflammatory cytokines on counteract-
ing the reparative role of Lcn2 has not been studied to date.
The results of the present study confirm that the addition of
the proinflammatory cytokine cocktail (TNF-, IL-1, and
IFN-) reduces renal regenerative effects in a period in which
regeneration is modulated by Lcn2. In addition, administration
of proinflammatory cytokines increased the expression of
proinflammatory cytokines such as MCP-1 (Fig. 5A), known
for its properties in the pathogenesis of renal I/R (13). Overall,
these findings indicate that the induction of a proinflammatory
environment is able to modify the regenerative profile induced
by Lcn2.
As Lcn2 levels were higher in the groups in which the
regeneration was decreased (see Lcn2 levels at 24 h or in the
cytokine-administered groups) (Fig. 6A), the observed effects
on regeneration cannot have been due to increased Lcn2
production. Devireddy and colleagues (9) presented evidence
indicating that expression of apo-NGAL (the human homolog
of Lcn2) and repression of its receptor (NGALR) may be
observed in other pathologies. However, to our knowledge no
data are reported concerning the effect of cytokines on Lcn2R
expression.
In adult kidneys, megalin appears to be the predominant
receptor for Lcn2 (2, 17). We therefore tested the expression of
megalin mRNA in the different experimental conditions. Our
results indicate that receptor expression was repressed in the
groups in which Lcn2 was overexpressed, and regeneration
was reduced (see Lcn2R and megalin expression in 24 h, or in
the cytokine-administered group). This suggested that the ef-
fect of cytokines on the regenerative action of Lcn2 could be
attributed to their effect on receptor expression, not to an effect
on Lcn2 expression or Lcn2 synthesis by itself. Thus the
inflammatory cytokines exert an effect on Lcn2 receptors.
The Lcn2-induced regenerative process could be described
as follows: inflammation due to kidney I/R appears to increase
endogenous Lcn2 production in renal tissue, already in the first
phases of reperfusion after the ischemic insult. This early
proinflammatory milieu appears to minimize the regenerative
effects of Lcn2. In later phases of reperfusion, transition from
a proinflammatory to an anti-inflammatory environment results
in an increased upregulation of Lcn2, which contributes to
repair.
In summary, we report that renal regeneration after I/R is
influenced by Lcn2 and cytokines. This Lcn2-mediated cell
regeneration is dependent on the inflammatory cytokines of the
milieu, as the presence of a proinflammatory cytokine cocktail
resulted in decreased Lcn2-induced cell regeneration. The
effects of cytokines on Lcn2 function may be mediated by their
action on the expression of the Lcn2 receptors.
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